Long-term follow-up shows 95% success rate, no serious complications in largest ADA-SCID gene therapy study to date ...

Earlier this month, Cryoport’s MVE Biological Solutions unveiled new integrated condition monitoring solutions for its MVE SC 4/2 V and 4/3 V series dewars, leveraging advanced Bluetooth and ...

Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...

The 2022 Option Agreement between Astellas and Taysha has expired. Regaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus on driving its long-term value w ...

The 2022 Option Agreement between Astellas and Taysha has expired Regaining full rights to TSHA-102 Rett syndrome program enables Taysha to focus on driving its long-term value with full strategic fle ...

Stevie Ringel is the founder of the Kizuna Foundation, an organization seeking a treatment for a genetic retinal mutation ...

Graham Johnson, a computational biologist and scientific illustrator at the Allen Institute for Cell Science, recalls ...

Whole genomic sequence technique can detect exceptional DNA features of breast cancer cells that help precision cancer therapy for over 15000 women a year.

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

Preliminary clinical data from the Phase 1 trial expected in 2H/2026REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; "Ono"), today announced the two-year efficacy and safety results from its MOTION Phase 3 study of ...